Journal of Clinical Medicine (Jun 2022)

PECAM-1 Is Down-Regulated in γδT Cells during Remission, but Up-Regulated in Relapse of Multiple Sclerosis

  • Michał K. Zarobkiewicz,
  • Izabela Morawska,
  • Wioleta Kowalska,
  • Paweł Halczuk,
  • Jacek Roliński,
  • Agnieszka A. Bojarska-Junak

DOI
https://doi.org/10.3390/jcm11113210
Journal volume & issue
Vol. 11, no. 11
p. 3210

Abstract

Read online

Introduction. PECAM-1 and NKRP1A are both involved in the vascular transmigration of T lymphocytes. Vascular transmigration is a crucial process in multiple sclerosis pathogenesis. Methods and aim. The current paper presents an analysis of PECAM-1 and NKRP1A expression on γδ T cells. Expression of PECAM-1 and NKRP1A on subsets of γδ T cells was performed with flow cytometry. Results. Based on the flow cytometry data, PECAM1 was slightly differentially modulated on γδ T cells—it was up-regulated during relapse, but down-regulated during remission. Moreover, a significant downregulation of CD3 expression was noted on γδ T cells from MS patients, most notably during relapse. Conclusions. This may be a sign of the overall activation of γδ T cells in the course of multiple sclerosis.

Keywords